ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Premier Inc

Premier Inc (PINC)

20.96
0.15
(0.72%)
Closed April 27 4:00PM
20.96
0.00
(0.00%)
After Hours: 7:18PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
20.96
Bid
20.68
Ask
21.26
Volume
1,195,560
20.67 Day's Range 21.105
18.89 52 Week Range 33.58
Market Cap
Previous Close
20.81
Open
20.80
Last Trade Time
Financial Volume
$ 25,035,849
VWAP
20.9407
Average Volume (3m)
1,781,441
Shares Outstanding
119,817,876
Dividend Yield
4.01%
PE Ratio
14.36
Earnings Per Share (EPS)
1.46
Revenue
1.34B
Net Profit
175.03M

About Premier Inc

Premier, Inc. is an American healthcare company, based in Charlotte, North Carolina. The company is listed on New York Stock Exchange Class A. In the early 2000s, Premier was a hospital buying group, pooling healthcare purchases to reduce prices. In 2017, Premier acquired Stanson Health for $51.5 mi... Premier, Inc. is an American healthcare company, based in Charlotte, North Carolina. The company is listed on New York Stock Exchange Class A. In the early 2000s, Premier was a hospital buying group, pooling healthcare purchases to reduce prices. In 2017, Premier acquired Stanson Health for $51.5 million. Show more

Sector
Management Services
Industry
Management Services
Headquarters
Charlotte, North Carolina, USA
Founded
1970
Premier Inc is listed in the Management Services sector of the NASDAQ with ticker PINC. The last closing price for Premier was $20.81. Over the last year, Premier shares have traded in a share price range of $ 18.89 to $ 33.58.

Premier currently has 119,817,876 shares outstanding. The market capitalization of Premier is $2.51 billion. Premier has a price to earnings ratio (PE ratio) of 14.36.

PINC Latest News

Premier, Inc. Declares Quarterly Cash Dividend

Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that its Board of Directors declared a cash dividend of $0.21 per share of Class A common...

Premier’s PINC AI™ and Fortune Name the Nation’s 100 Top Hospitals®

PINC AI™, the technology and services brand of Premier, Inc. (NASDAQ: PINC), today announced the nation’s 100 Top Hospitals®. The full list of recognized hospitals was published in an exclusive...

Premier, Inc. to Report Fiscal 2024 Third-Quarter Results and Host Conference Call on May 7, 2024

Premier, Inc. (NASDAQ: PINC) today announced that it will release financial results for its fiscal 2024 third quarter on Tuesday, May 7, 2024, at approximately 6:30 a.m. ET. The company will also...

Premier, Inc. to Participate in Barclays Global Healthcare Conference on March 12, 2024

Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that members of its management team will participate in a fireside chat at the Barclays...

PINC AI™ and Fortune Name the Nation’s 50 Top Cardiovascular Hospitals™

PINC AI™, the technology and services brand of Premier, Inc. (NASDAQ: PINC), today announced the nation’s 50 Top Cardiovascular Hospitals™. The full list of recognized hospitals was published in...

Premier, Inc.’s PINC AI™ Applied Sciences and Datavant Collaborate to Enable Next-Generation Clinical Trials

Builds on existing partnership by further leveraging the combined power of real-world data, real-world evidence and privacy-preserving record linkage technology to help solve key clinical trial...

Premier, Inc. Completes Strategic Review Process

Board Authorizes $1.0 Billion Share Repurchase Authorization, Including $400 Million Accelerated Share Repurchase (ASR) Transaction Company Will Seek Partners to Take Ownership of Some or All of...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.080.38314176245220.8821.320.6795184021.04677083CS
4-1.14-5.1583710407222.122.3320.58116126421.08867956CS
12-0.68-3.1423290203321.6422.8920.58178144121.29766243CS
261.68.2644628099219.3623.0118.89130895821.31259679CS
52-11.23-34.886610748732.1933.5818.89130028822.61093888CS
156-14.88-41.517857142935.8442.1518.8980435228.77473422CS
260-12.12-36.63845223733.0842.1518.8974550830.64604731CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BDRXBiodexa Pharmaceuticals PLC
$ 1.3254
(82.86%)
70.82M
IBRXImmunityBio Inc
$ 7.35
(43.84%)
40.28M
AGENAgenus Inc
$ 11.685
(40.78%)
3.37M
ULHUniversal Logistics Holdings Inc
$ 45.63
(38.74%)
484.22k
NIVFNewGenIvf Group Ltd
$ 1.77
(36.15%)
57.78M
MFImF International Ltd
$ 2.3153
(-77.82%)
21.23M
NWGLNature Wood Group Ltd
$ 5.05
(-70.03%)
2.48M
ICLKiClick Interactive Asia Group Ltd
$ 1.21
(-52.17%)
719.95k
NUWENewellis Inc
$ 0.1695
(-41.35%)
18.46M
SGBXSafe and Green Holdings Corporation
$ 0.1469
(-32.92%)
8.39M
PEGYPineapple Energy Inc
$ 0.065499
(26.20%)
325.57M
SQQQProShares UltraPro Short QQQ
$ 11.43
(-4.75%)
137.28M
INTCIntel Corporation
$ 31.88
(-9.20%)
119.84M
TSLATesla Inc
$ 168.29
(-1.11%)
109.84M
SOFISoFi Technologies Inc
$ 7.87
(3.69%)
88.63M

PINC Discussion

View Posts
PostTrifecta PostTrifecta 4 years ago
Looking Bullish!

Stock looking great on the charts with buy out rumors circulating. Expect price in mid 40s
👍️0
VisionTrade VisionTrade 9 years ago
I can believe "TWSI" is trading under a $1.00 with deals like this with In Premier, Inc. The financials of "TWSI" look strong after turning around HemCom Medical.

👍️0
Stock Rockstar Stock Rockstar 9 years ago
$TWSI HUGE Purchasing Agreement with Premier, Inc.!!

HemCon Medical Technologies, Inc. Awarded Hemostasis and Compression Products Agreement With Premier, Inc.

WESTPORT, Conn., Nov. 3, 2014 /PRNewswire/ -- HemCon Medical Technologies, Inc. ("HemCon"), a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. (TWSI) and a leading developer and marketer of advanced medical products, announced today that the company has been awarded a group purchasing agreement for Hemostasis and Compression Products with Premier, Inc. effective November 1, 2014. The new agreement (PP-CA-248) allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for the entire line of HemCon hemostatic products, including products such as the HemCon Patch® PRO, ideal for bleeding control following heart catheterizations, ChitoGauze® PRO for traumatic injuries and GuardaCare®XR Surgical, a must have tool for controlling bleeding and maintaining surgical field visibility in the operating room.

"HemCon is pleased to be included as a contracted supplier for Premier. Our company is committed to creating new healthcare products that drive improved patient safety and better clinical results across the continuum of care. We're excited that Premier will make our proprietary hemostatic products available to their members and support them in their efforts of improving patient care," said HemCon Chief Executive Officer and President, Michael Wax.

HemCon offers a comprehensive line of hemostatic products with a proven track record that quickly control all levels of bleeding. HemCon's proprietary chitosan technology provides a cost-effective hemostatic solution to treat low to heavy arterial bleeding, while also providing antibacterial properties. HemCon's ability to stop bleeding at all levels of the continuum of care allows hospitals to add efficiencies to their normal practices as well as greatly reducing everyday expenses, while improving patient outcomes.

About Premier, Inc.

Premier, Inc. is a leading healthcare improvement company, uniting an alliance of approximately 3,000 U.S. hospitals and 110,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and advisory and other services, Premier enables better care and outcomes at a lower cost. Premier, a Malcolm Baldrige National Quality Award recipient, plays a critical role in the rapidly evolving healthcare industry, collaborating with members to co-develop long-term innovations that reinvent and improve the way care is delivered to patients nationwide. Headquartered in Charlotte, N.C., Premier is passionate about transforming American healthcare. Please visit Premier's news and investor sites on www.premierinc.com; as well as Twitter, Facebook, LinkedIn, YouTube, Instagram, Foursquare and Premier's blog for more information about the company.

About HemCon Medical Technologies, Inc.

HemCon Medical Technologies Inc., is a wholly owned subsidiary of TriStar Wellness Solutions®, Inc. (TWSI). HemCon is a developer, manufacturer, and marketer of proprietary technologies for hemostatic devices for the control of bleeding resulting from trauma or surgery. HemCon was founded in 2001 and since then has been a supplier of medical devices to the military, emergency medical and law enforcement communities. This year the company received endorsement from the Tactical Combat Casualty Care (TCCC) and is an approved supplier of bandages and hemostatic devices to government agencies and allied militaries around the world. The company this year also launched a sales force dedicated to serving the hospital and clinical markets. Additional information is available at www.hemcon.com.

About TriStar Wellness Solutions

TriStar Wellness Solutions®, Inc. (TWSI) is a health and wellness company that targets under-met opportunities in the OTC and professional marketplace. TriStar is the owner of HemCon Medical Technologies Inc., a company dedicated to saving lives through innovative wound care solutions. It also owns the Beaute de Maman™ brand of women's health products. Additional information is available at www.tstarwellness.com and www.beautedemaman.com.
👍️0

Your Recent History

Delayed Upgrade Clock